Bebo HealthXPAR:MLBBO 47 Return-on-Tangible-Equity is 0.83% as of Dec. 2025, which is at its 10-year median of 0.83. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03. The stock has 3 warning signs investors should review. Among 1,056 Retail - Cyclical companies, Bebo Health ranks worse than 73.48% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Bebo Health's annualized net income for the quarter that ended in Dec. 2025 was €0.04 Mil. Bebo Health's average shareholder tangible equity for the quarter that ended in Dec. 2025 was €5.07 Mil. Therefore, Bebo Health's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 0.83%.
The historical rank and industry rank for Bebo Health's Return-on-Tangible-Equity or its related term are showing as below:
XPAR:MLBBO'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 0.32 Med: 0.83 Max: 85.45
Current: 0.83
During the past 7 years, Bebo Health's highest Return-on-Tangible-Equity was 85.45%. The lowest was 0.32%. And the median was 0.83%.
XPAR:MLBBO's Return-on-Tangible-Equity is ranked worse than 73.48% of 1056
companies
in the Retail - Cyclical industry
Industry Median: 8.325
vs XPAR:MLBBO: 0.83
Bebo Health (XPAR:MLBBO) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Bebo Health Return-on-Tangible-Equity Related Terms
Bebo Health Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Bebo Health's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLBBO vs CASY, WSM, DKS: Return-on-Tangible-Equity Comparison
For the Specialty Retail subindustry, Bebo Health's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bebo Health Return-on-Tangible-Equity vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bebo Health's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Bebo Health's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.83% mean?
Bebo Health (XPAR:MLBBO) has a Return-on-Tangible-Equity of 0.83% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Bebo Health and its competitors. This is near median its historical median of 0.83. Over the past decade, Bebo Health's Return-on-Tangible-Equity has ranged from 0.32 to 85.45. According to the industry distribution chart, Bebo Health ranks #776 out of 1056 companies in the Retail - Cyclical industry, placing it in the top 73.5%.
Is Bebo Health's Return-on-Tangible-Equity too high?
Bebo Health's current Return-on-Tangible-Equity of 0.83% is near median its 10-year median of 0.83. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 85.45. The Retail - Cyclical industry median Return-on-Tangible-Equity is 8.33. Bebo Health's value of 0.83% is 90% below this industry median. Based on the distribution chart, Bebo Health ranks #776 out of 1056 companies in the Retail - Cyclical industry, which is below the industry midpoint. Overall, Bebo Health has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's Return-on-Tangible-Equity compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Bebo Health ranks #776 out of 1056 companies for Return-on-Tangible-Equity. This places Bebo Health in the lower half of its industry. The industry median Return-on-Tangible-Equity is 8.33. Bebo Health's value of 0.83% is 90% below this benchmark. Historically, Bebo Health's own Return-on-Tangible-Equity has ranged from 0.32 to 85.45 over the past decade. While the company's 10-year median is 0.83 vs. the industry median of 8.33, Bebo Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Retail - Cyclical company?
The median Return-on-Tangible-Equity among Retail - Cyclical companies is 8.33, based on 1,056 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bebo Health's current Return-on-Tangible-Equity of 0.83% is 90% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Bebo Health and its competitors. For the Retail - Cyclical industry, the median Return-on-Tangible-Equity is 8.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bebo Health's current Return-on-Tangible-Equity is 0.83%, which is near median its own 10-year median of 0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Bebo Health (XPAR:MLBBO) has a current Return-on-Tangible-Equity of 0.83%. The stock's GF Value™ is €0.03, compared to a current price of €0.23 — trading 660% above its estimated fair value. The current Return-on-Tangible-Equity is 0.83%, which is near median its 10-year median of 0.83 and 90% below the Retail - Cyclical industry median of 8.33. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current Return-on-Tangible-Equity is 0.83% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?
Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued.
The current stock price of €0.23 is trading 660% above its estimated GF Value™ of €0.03.
Key valuation signals for XPAR:MLBBO:
Return-on-Tangible-Equity: 0.83% (near median its 10-year median of 0.83)
GF Value™: €0.03 vs. price of €0.23 (660% above fair value)
Industry Position: 90% below the Retail - Cyclical median (#776 of 1056)
No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBBO has been successfully added to your 